Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Radius Ventures, LLC was a venture capital firm founded in 1997 by Jordan S. Davis and Daniel C. Lubin. Based in the United States, the firm focused on building companies in the health and life sciences sectors. Over its operational period until 2024, Radius Ventures backed more than 40 venture-stage businesses, many of which achieved successful outcomes through initial public offerings or strategic acquisitions. The firm was known for its disciplined, domain-driven investment approach, primarily targeting healthcare technology, diagnostics, and therapeutics.
Throughout its history, Radius Ventures established a strong legacy in healthcare innovation, with a portfolio that included companies like Conor Medsystems and Tactile Medical. The firm emphasized active engagement with its portfolio companies, providing hands-on support and strategic guidance. Radius Ventures operated until 2024, when it wound down its operations, marking the end of an era for a firm that had significantly impacted the healthcare investment landscape.
Radius Ventures specialized in investing in healthcare technology, diagnostics, and therapeutics. The firm maintained a disciplined, domain-driven investment approach, focusing on companies that had the potential to transform patient care and improve health outcomes. Their investment strategy encompassed various stages, including Seed, Series A, and Series B, primarily within the United States. Radius Ventures sought to partner with entrepreneurs who demonstrated a strong vision and capability to innovate within the healthcare sector.
The firm’s thesis revolved around identifying and supporting companies capable of advancing medical innovation and improving patient care. Radius Ventures looked for startups that could demonstrate a clear path to market and a solid understanding of their target demographics. Their investment preferences included a hands-on approach, with board-level involvement and strategic guidance to help portfolio companies navigate the complexities of the healthcare market.
Radius Ventures had a diverse portfolio of over 40 companies, with notable successes and exits in the healthcare sector. Key portfolio companies included:
These companies exemplify Radius Ventures' commitment to investing in transformative healthcare solutions, many of which have achieved significant market success and contributed to advancements in patient care.
Jordan S. Davis: Managing Partner and Co-founder (1997 – 2024). He was known for his hands-on approach and strategic insights in building healthcare companies. Davis now serves as Managing Partner of JSD Capital LLC.
Daniel C. Lubin: Managing Partner and Co-Founder (1997 – 2024). Lubin was recognized for his network-driven approach and played a significant role in shaping the firm's investment platform. He continues as Chairman of Upsher Management Company.
Neenah Jain: Chief Financial Officer (2008 - 2024). Jain managed finance, administrative, and accounting operations, ensuring the firm's financial health during its operational years.
Vincent S. Conti: Venture Partner (2010 - 2024). Conti brought extensive experience as a former hospital executive and supported companies like Syft and Healthsense.
James M. Mead: Venture Partner (2004 - 2024). Mead, a former Vice Chairman and CEO of Capital BlueCross, provided governance support and payer perspective to portfolio companies.
George M. Milne, Jr., Ph.D.: Venture Partner (2012 - 2024). Milne had a distinguished career at Pfizer, where he served as Executive Vice President of Global R&D and President of Central Research.
Radius Ventures had a specific pitch process that involved visiting their official website at radiusventures.com. However, as the firm is no longer operational, there is no current pitch process available. Founders should not expect a response as Radius Ventures wound down its operations in December 2024.
Radius Ventures officially wound down its operations in December 2024, marking the end of its investment activities. The firm had been inactive since 2024, with no recent public blog activity detected. Throughout its history, Radius Ventures backed over 40 venture-stage businesses, achieving notable exits such as Conor Medsystems and Tactile Medical.
As of 2026, the legacy of Radius Ventures continues through its founders, who have transitioned to new roles in adjacent investment vehicles. Jordan Davis is now Managing Partner at JSD Capital LLC, while Daniel Lubin serves as Chairman of Upsher Management Company.
What investment criteria does Radius Ventures use?
Radius Ventures focused on healthcare technology, diagnostics, and therapeutics, targeting companies with the potential to transform patient care and improve health outcomes. They preferred to invest in Seed, Series A, and Series B stages.
How can founders pitch Radius Ventures?
Founders were encouraged to visit the official website at radiusventures.com for pitch inquiries, although the firm is no longer active as of 2024.
What makes Radius Ventures different from other investors?
Radius Ventures emphasized hands-on support, board-level involvement, and strategic guidance, providing more than just capital to its portfolio companies.
What is the geographic focus of Radius Ventures?
The firm primarily focused on investments within the United States, targeting companies that operated in the healthcare sector.
What was the fund size of Radius Ventures?
The specific fund size was not disclosed, but the firm backed over 40 companies during its operational period.
What is the current status of Radius Ventures?
Radius Ventures wound down its operations in December 2024 and is no longer an active investor.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.